Results 231 to 240 of about 1,192,855 (302)

Interleukin‐6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini   +13 more
wiley   +1 more source

SNUPN‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SNUPN‐related muscular dystrophy or LGMDR29 is a new entity that covers from a congenital or childhood onset pure muscular dystrophy to more complex phenotypes combining neurodevelopmental features, cataracts, or spinocerebellar ataxia. So far, 12 different variants have been described.
Nuria Muelas   +18 more
wiley   +1 more source

Identify Sensitive Periods for Onset and Resolution of Hypertension and Its Subtypes Over the Lifespan. [PDF]

open access: yesJ Clin Hypertens (Greenwich)
Meng X   +8 more
europepmc   +1 more source

Health and economic burden of herpes zoster in adults in Finland: A retrospective nationwide database study. [PDF]

open access: yesHum Vaccin Immunother
Kanerva M   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy